Listed

Cryo Cell International Inc: Form 10-Q for the period ended Aug 31, 2014

Filed with the SEC on Oct 15, 2014 and accepted by EDGAR at Oct 15, 2014, 21:18 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2014-08-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2014-06-01 to 2014-08-31$4.9mus-gaap:Revenues
Revenue9 months2013-12-01 to 2014-08-31$15.2mus-gaap:Revenues
Cost of revenue3 months2014-06-01 to 2014-08-31$1.5mus-gaap:CostOfServices
Cost of revenue9 months2013-12-01 to 2014-08-31$4.3mus-gaap:CostOfServices
Research and development3 months2014-06-01 to 2014-08-31$17.9kus-gaap:ResearchAndDevelopmentExpense
Research and development9 months2013-12-01 to 2014-08-31$50.5kus-gaap:ResearchAndDevelopmentExpense
Selling, general and administrative3 months2014-06-01 to 2014-08-31$2.9mus-gaap:SellingGeneralAndAdministrativeExpense
Selling, general and administrative9 months2013-12-01 to 2014-08-31$8.8mus-gaap:SellingGeneralAndAdministrativeExpense
Operating income3 months2014-06-01 to 2014-08-31$429.0kus-gaap:OperatingIncomeLoss
Operating income9 months2013-12-01 to 2014-08-31$1.8mus-gaap:OperatingIncomeLoss
Interest expense3 months2014-06-01 to 2014-08-31$309.3kus-gaap:InterestExpense
Interest expense9 months2013-12-01 to 2014-08-31$836.2kus-gaap:InterestExpense
Income tax3 months2014-06-01 to 2014-08-31$25.4kus-gaap:IncomeTaxExpenseBenefit
Income tax9 months2013-12-01 to 2014-08-31$98.1kus-gaap:IncomeTaxExpenseBenefit
Net income3 months2014-06-01 to 2014-08-31$236.6kus-gaap:NetIncomeLoss
Net income9 months2013-12-01 to 2014-08-31$849.5kus-gaap:NetIncomeLoss
Diluted EPS3 months2014-06-01 to 2014-08-31$0.02us-gaap:EarningsPerShareDiluted
Diluted EPS9 months2013-12-01 to 2014-08-31$0.08us-gaap:EarningsPerShareDiluted
Basic EPS3 months2014-06-01 to 2014-08-31$0.02us-gaap:EarningsPerShareBasic
Basic EPS9 months2013-12-01 to 2014-08-31$0.08us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2014-06-01 to 2014-08-3110,252,265 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Diluted shares (weighted)9 months2013-12-01 to 2014-08-3110,484,849 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow9 months2013-12-01 to 2014-08-31$1.3mus-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
Capital expenditure9 months2013-12-01 to 2014-08-31$93.5kus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Share repurchases9 months2013-12-01 to 2014-08-31$2.3mus-gaap:PaymentsForRepurchaseOfCommonStock
Cash and equivalentsAt period end2014-08-31$3.4mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2014-08-31$8.3mus-gaap:AssetsCurrent
Total assetsAt period end2014-08-31$10.1mus-gaap:Assets
Current liabilitiesAt period end2014-08-31$8.8mus-gaap:LiabilitiesCurrent
Long-term debtAt period end2014-08-31$2.3mus-gaap:LongTermDebtNoncurrent
Shareholders' equityAt period end2014-08-31−$10.2mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001193125-14-372812. Last ingested by Listed: Oct 24, 2026, 14:58 ET. Listed shows no prices and gives no investment advice.